Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 7, 2025

One Million Kids, One Mission: Sevaro & Yale School of Medicine Stroke Neurologists Unite to Teach Stroke Awareness

One Million Kids, One Mission: Sevaro & Yale School of Medicine Stroke Neurologists Unite to Teach Stroke Awareness

EAST BRUNSWICK, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Sevaro, the leading provider of AI-powered virtual neurology and intelligent analytics, has partnered with stroke neurologists at Yale School of Medicine as part of its ongoing Children’s Health …

Conversations Today to Empower Tomorrow: VITAS® Healthcare Elevates National Healthcare Decisions Day

Conversations Today to Empower Tomorrow: VITAS® Healthcare Elevates National Healthcare Decisions Day

MIAMI, April 07, 2025 (GLOBE NEWSWIRE) -- Only one in three adults in the United States have a written advance directive, a document critical in providing guidance to medical teams regarding one’s end-of-life wishes. As a pioneer and national leader in …

Prime Biome Reviews (SHOCKING RESEARCH EXPOSED): Does This Gut-Skin Link Actually Hold Up in 2025?

Prime Biome Reviews (SHOCKING RESEARCH EXPOSED): Does This Gut-Skin Link Actually Hold Up in 2025?

SEATTLE, WA, April 07, 2025 (GLOBE NEWSWIRE) --  PRIME BIOME In a world obsessed with gut health and skincare, Prime Biome has rapidly become one of the most talked-about supplements of 2025. Touted as a gut-skin breakthrough, this probiotic formula claims …

XTL Names Mr. Noam Band as its New Chief Executive Officer

XTL Names Mr. Noam Band as its New Chief Executive Officer

Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”) announced today the appointment of Noam Band as the Company’s …

NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th 

NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th 

LANGHORNE, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer …

Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products

Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products

CRANSTON, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global manufacturer of packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced it is …

Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology

Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology

Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially broad-ranging clinical relevance for multiple hepatobiliary diseases including progressive familial …

Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool

Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool

NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Certified Genetool (or the “Company”), a San Francisco-based …

Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions

Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions

ATLANTA , April 07, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced that seasoned healthcare compliance and privacy …

ImmuCell Hires Chief Financial Officer

ImmuCell Hires Chief Financial Officer

PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies

Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies

VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it will be …

Senti Bio Joins Webull Corporate Connect Service Platform

Senti Bio Joins Webull Corporate Connect Service Platform

Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for the treatment of acute myeloid leukemia (AML) Connect with the Company on Webull here SOUTH SAN FRANCISCO, …

Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025

Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025

TAMPA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors have approved a stock dividend of 0.35 per …

Nitric Boost Ultra Reviews (WARNING): Is This Male Performance Powder a Game-Changer or Just Clever Hype?

Nitric Boost Ultra Reviews (WARNING): Is This Male Performance Powder a Game-Changer or Just Clever Hype?

SEATTLE, WA, April 07, 2025 (GLOBE NEWSWIRE) --  NITRIC BOOST ULTRA That’s what we’re here to uncover. Because while over 43,000 men have already made the switch to Nitric Boost Ultra, most have no idea why it’s gaining traction. A powder that claims to “ …

Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity

Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity

Dr. Egler brings extensive experience in functional medicine leadership to Noom as it expands its services to meet consumer health demands across a wider range of medical issues NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital …

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …

Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center

Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center

RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced the successful completion of …

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize development pathways. NAPLES, Fla. and CAMBRIDGE, United …

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who completed 17 doses improved from moderate to mild AD within just 3 …

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service